Gapping down
In reaction to earnings/guidance:
- CTXS -2.3%, IDT -0.7%
Other news:
- OSMT -40.5% (prices offering of 14 mln ordinary shares of stock at $2.50 per share; co also priced warrants of up to 14 mln shares with exercise price of $3.10 per share), CRK -5.5% (announces the divestiture of Bakken shale assets)
- CTXS -2.3% (appoints Bob Calderoni as interim CEO, effective immediately; expects to report Q3 revenue at the midpoint to high end of prior guidance)
- VXX -2.2% (trading lower with strength in US futures)
- BMY -2% (provides update on Phase 2 Study of Deucravacitinib for moderate to severe ulcerative colitis; study did not meet primary nor secondary endpoints)
- DRIO -1.9% (to provide global company its integrated digital health management solution for diabetes, hypertension, and musculoskeletal health)
- AVT -1.5% (disclosed update for distribution relationship with Maxim Integrated)
Analyst comments:
- BOX -1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)